183 related articles for article (PubMed ID: 28384095)
41. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.
Cotterchio M; Kreiger N; Theis B; Sloan M; Bahl S
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1053-60. PubMed ID: 14578142
[TBL] [Abstract][Full Text] [Related]
42. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
43. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
Gapstur SM; Potter JD; Drinkard C; Folsom AR
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
[TBL] [Abstract][Full Text] [Related]
44. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.
Munsell MF; Sprague BL; Berry DA; Chisholm G; Trentham-Dietz A
Epidemiol Rev; 2014; 36(1):114-36. PubMed ID: 24375928
[TBL] [Abstract][Full Text] [Related]
45. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
46. Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort.
Horn-Ross PL; Canchola AJ; West DW; Stewart SL; Bernstein L; Deapen D; Pinder R; Ross RK; Anton-Culver H; Peel D; Ziogas A; Reynolds P; Wright W
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):405-11. PubMed ID: 15006916
[TBL] [Abstract][Full Text] [Related]
47. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
48. Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Miyagawa Y; Miyake T; Yanai A; Murase K; Imamura M; Ichii S; Takatsuka Y; Ito T; Hirota S; Saito M; Kotoura Y; Miyauchi K; Fujimoto Y; Hatada T; Sasa M; Miyoshi Y
Breast Cancer; 2015 Jul; 22(4):399-405. PubMed ID: 24000037
[TBL] [Abstract][Full Text] [Related]
49. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.
Zhang X; Smith-Warner SA; Collins LC; Rosner B; Willett WC; Hankinson SE
J Clin Oncol; 2012 Oct; 30(28):3468-77. PubMed ID: 22927520
[TBL] [Abstract][Full Text] [Related]
50. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
51. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
Lew JQ; Freedman ND; Leitzmann MF; Brinton LA; Hoover RN; Hollenbeck AR; Schatzkin A; Park Y
Am J Epidemiol; 2009 Aug; 170(3):308-17. PubMed ID: 19541857
[TBL] [Abstract][Full Text] [Related]
52. Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study.
Horn-Ross PL; Canchola AJ; Bernstein L; Clarke CA; Lacey JV; Neuhausen SL; Reynolds P; Ursin G
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2006-13. PubMed ID: 22832206
[TBL] [Abstract][Full Text] [Related]
53. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women.
Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A
Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112
[TBL] [Abstract][Full Text] [Related]
54. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
55. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
[TBL] [Abstract][Full Text] [Related]
56. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
Anderson LN; Cotterchio M; Boucher BA; Kreiger N
Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
[TBL] [Abstract][Full Text] [Related]
57. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
[TBL] [Abstract][Full Text] [Related]
58. Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.
Pizot C; Boniol M; Mullie P; Koechlin A; Boniol M; Boyle P; Autier P
Eur J Cancer; 2016 Jan; 52():138-54. PubMed ID: 26687833
[TBL] [Abstract][Full Text] [Related]
59. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
[TBL] [Abstract][Full Text] [Related]
60. Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study.
Cao S; Zhou J; Zhu Z; Wei F; Li W; Lu S; Su J; Yu H; Du W; Cui L; Wei P; Wu M
Breast Cancer Res Treat; 2019 Feb; 173(3):647-655. PubMed ID: 30368743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
